The Hong Kong company saw a reduction in body weight across both cohorts with no serious adverse events reported.

Two Omaha women lost more than 300 lbs. combined with injections of a GLP-1 drug, which are used increasingly for weight loss ...

Zealand’s CEO Adam Steensberg said that the company is “exactly where it wants to be” in terms of its partnering and ...

A study conducted using electronic health record data from a collective of U.S. health care systems found that most adults ...

While medications such as methadone, buprenorphine, and naltrexone are FDA-approved for treating opioid use disorder, they ...

Researchers had found in a new study that sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 ...

RAs, originally for diabetes, may impact brain health, finding potential benefits for dementia and addiction but inconsistent ...

The developer of the highly successful da Vinci surgical robot, the company has long enjoyed a dominant market position in ...

Compared to usual care, GLP-1RA use was linked to a reduced risk of various neurocognitive disorders, substance use and psychotic disorders, seizures, coagulation disorders, cardiometabolic ...

Studies in patients with type 2 diabetes are needed to further assess and allow comparison of several GLP-1RA agents' impact on steady-state pharmacokinetics and pharmacodynamics of concomitant ...

We independently screened all abstracts for eligibility, which consisted of studies reporting the effects of GLP-1RA administration on the pharmacokinetics and pharmacodynamics of concurrent oral ...

A nonrandomized clinical trial found that HbA1c levels decreased in a diverse group of adults with type 2 diabetes after ...